Clinical trial
A Phase 2, Randomized, Double-Blind, Multi-center Study Comparing CLP Versus Placebo in Heart Failure Patients With Chronic Kidney Disease
NCT01265524 is registered in ClinicalTrials.gov with Sorbent Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-Blind, Multi-center Study Comparing CLP Versus Placebo in Heart Failure Patients With Chronic Kidney Disease
- Lead sponsor
- Sorbent Therapeutics
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- Not reported
- Enrollment
- 113 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.